Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
36.11
-2.58 (-6.67%)
At close: May 18, 2026, 4:00 PM EDT
36.15
+0.04 (0.12%)
After-hours: May 18, 2026, 7:48 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $2.57 billion as of May 18, 2026. Its market cap has increased by 63.21% in one year.
Market Cap
2.57B
Enterprise Value
1.11B
1-Year Change
63.21%
Ranking
Category
Stock Price
$36.11
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $2.57B, an increase of 367.61%. That is a compound annual growth rate of 60.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.75B | -42.82% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 2.97B |
| Denali Therapeutics | 2.96B |
| Alumis | 2.92B |
| Dyne Therapeutics | 2.86B |
| Beam Therapeutics | 2.78B |
| Soleno Therapeutics | 2.76B |
| Kailera Therapeutics | 2.73B |
| Tarsus Pharmaceuticals | 2.69B |